A Model for Early Endoscopic Detection of High-Risk Gastroesophageal Varices in Children With Biliary Atresia

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Oanez Ackermann ◽  
Paul de Boissieu ◽  
Olivier Bernard ◽  
Emmanuel Gonzalès ◽  
Emmanuel Jacquemin ◽  
...  
Keyword(s):  
High Risk ◽  
Biliary Atresia ◽  
Gastroesophageal Varices

Progression to High-Risk Gastroesophageal Varices in Children With Biliary Atresia With Low-Risk Signs at First Endoscopy

2015 ◽  
Vol 60 (5) ◽  
pp. 664-668 ◽  
Author(s):  
Mathieu Duché ◽  
Béatrice Ducot ◽  
Oanez Ackermann ◽  
Emmanuel Jacquemin ◽  
Olivier Bernard
Keyword(s):  
High Risk ◽  
Biliary Atresia ◽  
Low Risk ◽  
Gastroesophageal Varices

Experience With Endoscopic Management of High-Risk Gastroesophageal Varices, With and Without Bleeding, in Children With Biliary Atresia

2013 ◽  
Vol 145 (4) ◽  
pp. 801-807 ◽  
Author(s):  
Mathieu Duché ◽  
Béatrice Ducot ◽  
Oanez Ackermann ◽  
Catherine Baujard ◽  
Laurent Chevret ◽  
...  
Keyword(s):  
High Risk ◽  
Biliary Atresia ◽  
Endoscopic Management ◽  
Gastroesophageal Varices

scholarly journals Prevention and Management of Variceal Hemorrhage

2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
Dong Hyun Kim ◽  
Jun Yong Park
Keyword(s):  
High Risk ◽  
Endoscopic Sclerotherapy ◽  
Variceal Hemorrhage ◽  
Gastroesophageal Varices ◽  
Mortality And Morbidity ◽  
First Line Therapy ◽  
Advanced Cirrhosis ◽  
Proven Efficacy ◽  
Advanced Liver Cirrhosis ◽  
Small Varices

Variceal hemorrhage is a common and devastating complication of portal hypertension and is a leading cause of death in patients with cirrhosis. The management of gastroesophageal varices has evolved over the last decade resulting in improved mortality and morbidity rates. Regarding the primary prevention of variceal hemorrhaging, nonselectiveβ-blockers should be the first-line therapy in all patients with medium to large varices and in patients with small varices associated with high-risk features such as red wale marks and/or advanced cirrhosis. EVL should be offered in cases of intolerance or side effects toβ-blockers, or for patients at high-risk for variceal bleeding who have medium or large varices with red wale marks or advanced liver cirrhosis. In acute bleeding, vasoactive agents should be initiated along with antibiotics followed by EVL or endoscopic sclerotherapy (if EVL is technically difficult) within the first 12 hours of presentation. Where available, terlipressin is the preferred agent because of its safety profile and it represents the only drug with a proven efficacy in improving survival. All patients surviving an episode of bleeding should undergo further prophylaxis to prevent rebleeding with EVL and nonselectiveβ-blockers.

Spleen stiffness by 2‐D shear wave elastography is the most accurate predictor of high‐risk esophagogastric varices in children with biliary atresia

2019 ◽  
Vol 49 (10) ◽  
pp. 1162-1168 ◽  
Author(s):  
Shinya Yokoyama ◽  
Masatoshi Ishigami ◽  
Takashi Honda ◽  
Teiji Kuzuya ◽  
Yoji Ishizu ◽  
...  
Keyword(s):  
High Risk ◽  
Biliary Atresia ◽  
Shear Wave ◽  
Shear Wave Elastography ◽  
Accurate Predictor ◽  
Esophagogastric Varices ◽  
Spleen Stiffness

Endoscopic variceal ligation in the management of gastroesophageal varices in postoperative biliary atresia

1998 ◽  
Vol 33 (11) ◽  
pp. 1628-1632 ◽  
Author(s):  
Takashi Sasaki ◽  
Toshimichi Hasegawa ◽  
Kiyokazu Nakajima ◽  
Hirofumi Tanano ◽  
Masafumi Wasa ◽  
...  
Keyword(s):  
Biliary Atresia ◽  
Endoscopic Variceal Ligation ◽  
Gastroesophageal Varices

scholarly journals Successful Endoscopic Injection Sclerotherapy of High-Risk Gastroesophageal Varices in a Cirrhotic Patient with Hemophilia A

2010 ◽  
Vol 2010 ◽  
pp. 1-5 ◽  
Author(s):  
Kohei Fukumoto ◽  
Hideyuki Konishi ◽  
Koichi Soga ◽  
Ki-ichiro Miyawaki ◽  
Hitoshi Okano ◽  
...  
Keyword(s):  
High Risk ◽  
Cirrhotic Patient ◽  
Hemophilia A ◽  
Massive Bleeding ◽  
Injection Sclerotherapy ◽  
Upper Gastrointestinal Endoscopy ◽  
Endoscopic Injection Sclerotherapy ◽  
Endoscopic Injection ◽  
Gastroesophageal Varices ◽  
Before And After

A 68-year-old man with hemophilia A and liver cirrhosis caused by hepatitis C virus was referred to our hospital to receive prophylactic endoscopic treatment for gastroesophageal varices (GOV). He had large, tense, and winding esophageal varices (EV) with cherry red spots extending down to lesser curve, predicting the likelihood of bleeding. Esophageal endoscopic injection sclerotherapy (EIS) was performed with a total 15 mL of 5% ethanolamine oleate with iopamidol (EOI). Radiographic imaging during EIS demonstrated that 5% EOI reached the afferent vein of the varices. He was administered sufficient factor VIII concentrate before and after EIS to prevent massive bleeding from the varices. Seven days after EIS, upper gastrointestinal endoscopy (UGIE) showed that the varices were eradicated almost completely. Eighteen months after EIS, the varices continued to diminish. We report a successful case of safe and effective EIS for GOV in a high-risk cirrhotic patient with hemophilia A.

Sign in / Sign up

Export Citation Format

Share Document